0,837  0,004  Caspase 3 stimulant
0,821  0,004  NOS2 expression inhibitor
0,797  0,004  Cardiovascular analeptic
0,764  0,016  Caspase 9 stimulant
0,766  0,020  Antiinflammatory
0,764  0,021  Apoptosis agonist
0,746  0,015  Antineoplastic (breast cancer)
0,729  0,005  5 Hydroxytryptamine release stimulant
0,725  0,005  Antineoplastic (brain cancer)
0,722  0,005  Antioxidant
0,711  0,005  Cardioprotectant
0,720  0,016  Antineoplastic (lung cancer)
0,706  0,005  Antimitotic
0,704  0,005  Antineoplastic (glioma)
0,692  0,021  Transcription factor NF kappa B inhibitor
0,678  0,013  Alzheimer's disease treatment
0,679  0,016  Antineoplastic (colorectal cancer)
0,674  0,015  Antineoplastic (colon cancer)
0,667  0,012  Antihypercholesterolemic
0,658  0,017  Antileukemic
0,655  0,017  15-Lipoxygenase inhibitor
0,642  0,012  Chemopreventive
0,642  0,014  Aldehyde oxidase inhibitor
0,635  0,007  UGT1A6 substrate
0,632  0,005  Genotoxic
0,628  0,004  ICAM1 expression inhibitor
0,619  0,003  Pneumotoxic
0,623  0,009  Nitric oxide antagonist
0,620  0,007  Free radical scavenger
0,615  0,003  VCAM1 expression inhibitor
0,622  0,015  Antiparkinsonian
0,606  0,018  Prostate cancer treatment
0,609  0,024  TNF expression inhibitor
0,584  0,009  Antipyretic
0,578  0,004  Cyclic AMP phosphodiesterase inhibitor
0,564  0,004  Diabetic nephropathy treatment
0,568  0,010  Antiamyloidogenic
0,556  0,015  UGT1A9 substrate
0,546  0,015  CYP2C19 inhibitor
0,533  0,009  Antimutagenic
0,533  0,009  Vasodilator
0,537  0,022  Antineoplastic (ovarian cancer)
0,505  0,002  Nitric-oxide synthase stimulant
0,509  0,013  Antineoplastic (glioblastoma multiforme)
0,499  0,004  Estrogen agonist
0,510  0,019  Apoptosis antagonist
0,505  0,024  Cytotoxic
0,492  0,012  Antidiabetic symptomatic
0,491  0,012  UGT2B4 substrate
0,497  0,019  Lipoxygenase inhibitor
0,520  0,044  Antidiabetic
0,520  0,044  Cyclophilin D inhibitor
0,494  0,023  Antineoplastic (cervical cancer)
0,486  0,018  Antiprotozoal (Leishmania)
0,475  0,008  Melanin inhibitor
0,468  0,005  UGT2B15 substrate
0,533  0,071  Alpha-glucosidase inhibitor
0,465  0,006  5 Hydroxytryptamine uptake stimulant
0,480  0,022  Cytostatic
0,489  0,036  Antipruritic, allergic
0,481  0,032  Vasodilator, peripheral
0,474  0,026  Hepatic disorders treatment
0,450  0,005  Glutathione S-transferase substrate
0,465  0,021  Proliferative diseases treatment
0,478  0,037  Histamine release inhibitor
0,446  0,010  Tubulin antagonist
0,441  0,008  Amylase inhibitor
0,444  0,013  UGT1A1 substrate
0,457  0,027  CTGF expression inhibitor
0,454  0,026  Sensitization
0,428  0,004  Cystathionine beta-synthase inhibitor
0,448  0,028  Antineoplastic (pancreatic cancer)
0,425  0,009  GST M1-1 substrate
0,433  0,027  Antineoplastic (non-small cell lung cancer)
0,439  0,033  Antineoplastic (melanoma)
0,405  0,004  Histone deacetylase SIRT1 stimulant
0,405  0,004  Histone deacetylase stimulant
0,412  0,012  Skin whitener
0,408  0,013  Hepatoprotectant
0,437  0,043  Ulceration
0,397  0,006  Antidiarrheal
0,424  0,034  AR expression inhibitor
0,416  0,028  Mutagenic
0,429  0,045  CYP2C9 inhibitor
0,411  0,032  Vasodilator, coronary
0,388  0,012  UGT1A3 substrate
0,375  0,003  Estrogen receptor beta agonist
0,402  0,038  NOS3 expression inhibitor
0,373  0,014  UGT2B7 substrate
0,366  0,008  Neurotrophic factor enhancer
0,384  0,027  Amyloid beta aggregation inhibitor
0,360  0,005  Beta glucuronidase inhibitor
0,377  0,029  Antineoplastic (renal cancer)
0,398  0,051  Antiallergic
0,392  0,046  Respiratory analeptic
0,353  0,013  Topoisomerase II inhibitor
0,400  0,062  CYP3A4 substrate
0,350  0,012  NOS3 expression enhancer
0,352  0,015  Antipruritic, non-allergic
0,359  0,022  Antineoplastic (sarcoma)
0,400  0,068  GST A substrate
0,406  0,074  Antibacterial
0,377  0,045  CYP2C19 substrate
0,345  0,016  Antineoplastic (squamous cell carcinoma)
0,359  0,030  Antineoplastic (small cell lung cancer)
0,368  0,046  Analeptic
0,349  0,026  UDP-glucuronosyltransferase substrate
0,341  0,020  Antihypotensive
0,359  0,038  DNA damaging
0,358  0,044  Calcium channel activator
0,361  0,048  CYP1A2 substrate
0,350  0,038  Hypoglycemic
0,321  0,008  Carcinogenic, group 1
0,361  0,051  Antiischemic
0,333  0,025  UGT1A4 substrate
0,309  0,005  Estrogen receptor beta antagonist
0,352  0,049  Antiosteoporotic
0,307  0,005  UGT2B10 substrate
0,330  0,032  Peroxidase inhibitor
0,337  0,040  Superoxide dismutase inhibitor
0,338  0,041  Antineoplastic (lymphoma)
0,369  0,074  CYP2C9 substrate
0,300  0,006  Beta amyloid protein antagonist
0,298  0,006  Estrogen antagonist
0,323  0,033  Antihypertriglyceridemic
0,293  0,004  Carcinogenic, group 2A
0,304  0,016  GST P1-1 substrate
0,298  0,011  5-Lipoxygenase inhibitor
0,335  0,048  Chemoprotective
0,314  0,029  Antihelmintic
0,321  0,038  Antiparasitic
0,294  0,013  Antineoplastic (bone cancer)
0,338  0,057  CYP3A4 inhibitor
0,297  0,018  Monophenol monooxygenase inhibitor
0,343  0,068  Bone diseases treatment
0,313  0,039  Psychostimulant
0,339  0,067  FMO1 substrate
0,314  0,044  Vascular (periferal) disease treatment
0,283  0,013  UGT2B9 substrate
0,281  0,013  Topoisomerase I inhibitor
0,276  0,009  UGT2B1 substrate
0,274  0,008  Alpha 2a adrenoreceptor antagonist
0,321  0,056  Hypoxia-inducible factor 1 alpha inhibitor
0,278  0,012  LDLR expression enhancer
0,295  0,030  P-glycoprotein inhibitor
0,280  0,016  Acetylcholinesterase inhibitor
0,278  0,015  Succinate dehydrogenase inhibitor
0,319  0,057  Antineoplastic (osteosarcoma)
0,342  0,082  Stroke treatment
0,332  0,072  Cholesterol antagonist
0,278  0,022  Cholinergic
0,285  0,038  Abortion inducer
0,305  0,058  Antihypoxic
0,339  0,093  Immunosuppressant
0,302  0,058  CYP1A2 inhibitor
0,259  0,016  Antifungal enhancer
0,284  0,042  Tyrosine 3 hydroxylase inhibitor
0,251  0,010  Alpha 2c adrenoreceptor antagonist
0,249  0,009  Microtubule formation inhibitor
0,250  0,011  Alpha 2 adrenoreceptor antagonist
0,250  0,016  SULT1A3 substrate
0,290  0,056  Antineoplastic (liver cancer)
0,246  0,015  VEGF expression inhibitor
0,291  0,059  Radiosensitizer
0,257  0,029  Antineoplastic (carcinoma)
0,359  0,132  Antineoplastic (solid tumors)
0,252  0,026  Lipid peroxidase inhibitor
0,278  0,052  Antineoplastic (lymphocytic leukemia)
0,226  0,004  Estrogen receptor alpha agonist
0,235  0,014  Antibacterial (Helicobacter pylori)
0,292  0,073  Spasmolytic
0,286  0,069  Antidiabetic (type 2)
0,230  0,015  Expectorant
0,244  0,033  Antihelmintic (Nematodes)
0,226  0,016  Antihemorrhagic
0,240  0,030  Interferon gamma antagonist
0,271  0,065  Tumour necrosis factor alpha release inhibitor
0,210  0,007  Macrophage migration inhibitory factor inhibitor
0,212  0,011  Mucolytic
0,219  0,018  Arachidonic acid antagonist
0,289  0,089  Sodium/bile acid cotransporter inhibitor
0,312  0,115  Antiprotozoal
0,241  0,047  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,284  0,089  12-Lipoxygenase inhibitor
0,328  0,135  5 Hydroxytryptamine release inhibitor
0,225  0,034  Protein kinase stimulant
0,229  0,038  Acaricide
0,214  0,024  Cholesterol synthesis inhibitor
0,270  0,084  Antineoplastic (multiple myeloma)
0,278  0,093  CYP2D6 substrate
0,199  0,015  Topoisomerase II alpha inhibitor
0,201  0,018  Cyclooxygenase 3 inhibitor
0,238  0,056  Anesthetic general
0,204  0,024  Antitussive
0,235  0,056  Sedative
0,224  0,045  Mcl-1 antagonist
0,201  0,021  Carcinogenic, group 2B
0,190  0,011  Dopamine D1 antagonist
0,236  0,059  ErbB-1 antagonist
0,259  0,087  Radioprotector
0,185  0,013  Creatine kinase inhibitor
0,202  0,033  M18 aspartyl aminopeptidase inhibitor
0,176  0,007  UGT2B11 substrate
0,183  0,015  Antineoplastic (uterine cancer)
0,216  0,048  Prostatic (benign) hyperplasia treatment
0,243  0,075  Embryotoxic
0,264  0,096  Antidepressant
0,268  0,102  Mood disorders treatment
0,270  0,105  Antihypertensive
0,175  0,009  Beta tubulin antagonist
0,183  0,019  Sulfotransferase substrate
0,275  0,112  Antineoplastic (endocrine cancer)
0,191  0,028  Toll-Like receptor 2 antagonist
0,204  0,040  Aldehyde oxidase substrate
0,242  0,078  Teratogen
0,172  0,010  Postmenopausal disorders treatment
0,202  0,040  Skeletal muscle relaxant
0,236  0,074  Cardiodepressant
0,184  0,023  Adenylate cyclase stimulant
0,227  0,067  RNA-directed DNA polymerase inhibitor
0,179  0,019  Gastritis treatment
0,182  0,023  SULT1A1 substrate
0,165  0,008  Alpha tubulin antagonist
0,199  0,043  Antiparkinsonian, tremor relieving
0,197  0,042  Antirickettsial
0,246  0,093  Lipoprotein disorders treatment
0,217  0,064  Carcinogenic
0,183  0,032  Alkylator
0,210  0,060  CYP2B6 inhibitor
0,160  0,013  Keratolytic
0,163  0,020  Ca2+-transporting ATPase inhibitor
0,163  0,024  Carbonic anhydrase III inhibitor
0,222  0,083  Angiogenesis stimulant
0,149  0,012  Estrogen receptor alpha antagonist
0,164  0,027  Vanilloid 1 agonist
0,152  0,019  Antifungal (Pneumocystis)
0,151  0,019  Acetylcholine M3 receptor agonist
0,216  0,084  Hypolipemic
0,192  0,060  Muscle relaxant
0,153  0,021  Prolactin inhibitor
0,159  0,028  Carbonic anhydrase XV inhibitor
0,201  0,073  Insulin sensitizer
0,137  0,009  Glycine receptor agonist
0,226  0,098  Antiprotozoal (Trypanosoma)
0,198  0,070  DNA methyltransferase I inhibitor
0,155  0,030  Bronchodilator
0,133  0,010  Granulocyte macrophage colony stimulating factor agonist
0,164  0,043  Skin irritative effect
0,127  0,006  Topoisomerase II beta inhibitor
0,163  0,042  DNA polymerase I inhibitor
0,149  0,029  AMP-activated protein kinase stimulant
0,146  0,027  HIV-1 integrase (Overall Integration) inhibitor
0,180  0,062  Toxic, respiratory center
0,139  0,021  Histidine decarboxylase inhibitor
0,225  0,108  Antineurogenic pain
0,199  0,082  Platelet aggregation inhibitor
0,141  0,026  Electron transport complex I inhibitor
0,181  0,066  Tumour necrosis factor antagonist
0,148  0,035  Contraceptive female
0,185  0,072  Antiviral (Hepatitis)
0,155  0,044  Protein-tyrosine phosphatase 1B inhibitor
0,131  0,024  Paget's disease treatment
0,169  0,063  Protein-tyrosine phosphatase inhibitor
0,130  0,028  Actinic keratosis treatment
0,182  0,081  Platelet adhesion inhibitor
0,142  0,043  Papain-like protease (SARS coronavirus) inhibitor
0,106  0,007  Kinesin-like protein 1 inhibitor
0,106  0,007  Kinesin antagonist
0,137  0,038  HDL-cholesterol increasing
0,150  0,052  Bipolar disorder treatment
0,186  0,088  DNA methylase inhibitor
0,157  0,059  Mannose-6-phosphate isomerase inhibitor
0,101  0,006  Postcoital contraceptive
0,099  0,004  Melatonin 1 agonist
0,271  0,177  Antiarthritic
0,181  0,087  Antiviral (Influenza)
0,115  0,021  Dopamine agonist
0,126  0,033  GST T1-1 substrate
0,120  0,029  NAD(P)H dehydrogenase (quinone) inhibitor
0,127  0,036  Antineoplastic antibiotic
0,161  0,070  Eye irritation, high
0,146  0,055  Heat shock protein 70 antagonist
0,139  0,050  Coagulant
0,118  0,030  Carbonic anhydrase VI inhibitor
0,169  0,081  Lipocortins synthesis antagonist
0,177  0,090  Non-steroidal antiinflammatory agent
0,130  0,044  Alpha adrenoreceptor antagonist
0,144  0,059  Farnesoid X receptor antagonist
0,097  0,012  Glutamate (mGluR7) antagonist
0,092  0,009  Transcription factor RelA inhibitor
0,114  0,032  Carbonic anhydrase XIII inhibitor
0,113  0,031  Ornithine decarboxylase inhibitor
0,140  0,059  Antiseptic
0,106  0,026  Na+ K+ transporting ATPase inhibitor
0,165  0,085  Antineoplastic (gastric cancer)
0,122  0,043  DOPA decarboxylase inhibitor
0,144  0,065  Pregnane X receptor agonist
0,215  0,136  Antifungal
0,083  0,005  Melatonin agonist
0,111  0,034  NADH dehydrogenase inhibitor
0,101  0,024  Estrogen-related receptor beta agonist
0,129  0,052  Alcohol dehydrogenase substrate
0,143  0,067  CNS active muscle relaxant
0,216  0,141  FMO3 substrate
0,102  0,027  Alpha adrenoreceptor agonist
0,121  0,047  Xanthine oxidase inhibitor
0,127  0,052  Constipation treatment
0,104  0,029  Vanilloid agonist
0,127  0,053  Antiviral (Influenza B)
0,103  0,029  Glycine receptor antagonist
0,223  0,150  Antithrombotic
0,101  0,028  Thioredoxin reductase inhibitor
0,113  0,041  Antineoplastic alkaloid
0,098  0,027  HIV-1 integrase (3'-Processing) inhibitor
0,150  0,080  Neuropathy treatment
0,080  0,009  Dopamine D3 agonist
0,152  0,082  Uterine stimulant
0,106  0,037  Bile acid receptor antagonist
0,122  0,053  EphA2 antagonist
0,116  0,049  Urease inhibitor
0,077  0,009  Alpha 1L adrenoreceptor antagonist
0,095  0,028  Narcotic antagonist
0,160  0,093  Phobic disorders treatment
0,101  0,034  Antiprotozoal activity enhancer
0,144  0,078  Antidote
0,090  0,024  Aromatase inhibitor
0,121  0,057  Alpha 2b adrenoreceptor antagonist
0,131  0,067  Antihelmintic (Trematoda)
0,143  0,079  MAP kinase 3 inhibitor
0,176  0,112  Antialcoholic
0,084  0,020  SULT2A1 substrate
0,135  0,073  Contraceptive
0,070  0,008  Dopamine D5 agonist
0,117  0,056  Choleretic
0,100  0,039  ATPase (Vacuolar H+) inhibitor
0,065  0,005  Sodium/glucose cotransporter 2 inhibitor
0,125  0,066  Antiviral (Hepatitis B)
0,073  0,014  Glucose-6-phosphate translocase inhibitor
0,071  0,014  Dopamine D5 antagonist
0,108  0,051  Antiadrenergic
0,080  0,025  Neuraminidase inhibitor
0,108  0,053  Anabolic
0,105  0,050  Adrenaline antagonist
0,071  0,016  Alpha-mannosidase inhibitor
0,108  0,054  Chronic obstructive bronchitis treatment
0,087  0,033  Leukotriene synthesis inhibitor
0,084  0,031  Secretase beta inhibitor
0,085  0,032  Antitreponemal
0,140  0,088  GABA C receptor rho-2 antagonist
0,099  0,047  Androgen antagonist
0,106  0,055  Dementia treatment
0,253  0,202  Calcium channel L-type activator
0,061  0,011  Glucocorticoid antagonist
0,076  0,026  Antimycoplasmal
0,103  0,053  Breast cancer-resistant protein inhibitor
0,138  0,088  Phospholipase A2 inhibitor
0,125  0,076  Cyclooxygenase 1 inhibitor
0,103  0,054  Vascular dementia treatment
0,061  0,014  Progesterone antagonist
0,073  0,028  Androgen agonist
0,049  0,005  Sodium/glucose cotransporter inhibitor
0,230  0,186  Atherosclerosis treatment
0,170  0,127  Antiviral (Ebola)
0,109  0,066  GABA C receptor antagonist
0,057  0,014  Guanylate cyclase inhibitor
0,066  0,023  Ryanodine receptor antagonist
0,097  0,054  Alpha 2d adrenoreceptor antagonist
0,122  0,080  NADPH oxidase inhibitor
0,070  0,028  Alpha 1 adrenoreceptor agonist
0,137  0,094  MAP kinase kinase 4 inhibitor
0,142  0,099  Prostate disorders treatment
0,059  0,016  Microtubule stabilization
0,075  0,033  HIV-1 integrase (Strand Transfer) inhibitor
0,133  0,090  Antiviral (Influenza A)
0,078  0,035  Anticholelithogenic
0,093  0,051  Antiviral (Hepatitis A)
0,071  0,030  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,080  0,038  HIV-1 integrase inhibitor
0,074  0,033  Glutamate (mGluR6) antagonist
0,126  0,086  Neurotrophic factor
0,053  0,013  Hypogonadism treatment
0,088  0,048  D-Ala-D-Ala ligase inhibitor
0,081  0,042  Lipase inhibitor
0,082  0,043  SULT1A2 substrate
0,188  0,150  Flavin-containing monooxygenase substrate
0,099  0,062  UDP-glucose 4-epimerase inhibitor
0,088  0,051  mTOR complex 2 inhibitor
0,046  0,010  Tubulin agonist
0,041  0,005  Dopamine D1 agonist
0,119  0,083  Phosphodiesterase inhibitor
0,055  0,020  Mannosidase inhibitor
0,057  0,023  Potassium channel Kv1.3 blocker
0,147  0,112  Phospholipase C inhibitor
0,059  0,025  Vanilloid 2 antagonist
0,108  0,075  Aldehyde dehydrogenase substrate
0,101  0,068  Toll-Like receptor 4 antagonist
0,043  0,012  Nucleoside transporters inhibitor
0,136  0,105  CF transmembrane conductance regulator agonist
0,143  0,114  ATPase inhibitor
0,059  0,031  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,086  0,058  Calcium antagonist
0,060  0,032  Aldose reductase inhibitor
0,077  0,049  GABA B receptor agonist
0,067  0,039  Neuraminidase (influenza) inhibitor
0,090  0,063  Restless leg syndrome treatment
0,034  0,008  Sodium/glucose cotransporter 1 inhibitor
0,058  0,031  Acetylcholine M2 receptor agonist
0,112  0,086  Alpha-N-acetylglucosaminidase inhibitor
0,129  0,104  Sigma receptor agonist
0,101  0,076  Multidrug resistance-associated protein 1 inhibitor
0,065  0,040  Calcium channel P-type blocker
0,060  0,035  Lipocortins synthesis agonist
0,054  0,030  Anesthetic inhalation
0,088  0,066  Glutamate release inhibitor
0,104  0,082  Photosensitizer
0,052  0,031  Squalene epoxidase inhibitor
0,041  0,021  Vanilloid 3 antagonist
0,045  0,025  Cathepsin L2 inhibitor
0,087  0,069  SULT1E1 substrate
0,040  0,022  Glutamate (mGluR8) agonist
0,213  0,194  Antiobesity
0,102  0,084  Acetylcholine release stimulant
0,061  0,043  Dopamine D3 antagonist
0,115  0,098  Antianorexic
0,078  0,061  Adrenaline agonist
0,022  0,006  NMDA receptor phencyclidine site antagonist
0,041  0,025  Cholesterol absorption inhibitor
0,180  0,165  Transcription factor STAT3 inhibitor
0,090  0,075  Phosphodiesterase 6D inhibitor
0,034  0,020  Catechol O-methyltransferase inhibitor
0,175  0,161  DNA synthesis inhibitor
0,159  0,147  Immunostimulant
0,104  0,092  Growth stimulant
0,128  0,117  Aldose reductase substrate
0,060  0,049  Antiviral (Parainfluenza)
0,041  0,030  Kainate receptor agonist
0,191  0,181  Angiogenesis inhibitor
0,120  0,110  Antiviral (Herpes)
0,032  0,023  Estrogen-related receptor beta antagonist
0,062  0,052  Beta adrenoreceptor antagonist
0,078  0,068  Ca(v)3.1 blocker
0,032  0,023  Glutamate (mGluR3) agonist
0,066  0,057  Dopamine antagonist
0,121  0,112  Heat shock protein 90 antagonist
0,114  0,106  Cyclooxygenase inhibitor
0,023  0,015  Prostaglandin F2 alpha agonist
0,056  0,047  Heat shock protein 90 beta antagonist
0,096  0,088  Antifungal (Aspergillus)
0,056  0,049  Adrenaline uptake inhibitor
0,121  0,113  MAP3K9 inhibitor
0,076  0,069  Glutathione S-transferase inhibitor
0,062  0,055  Phosphofructokinase-1 inhibitor
0,039  0,032  Estradiol 17 beta-dehydrogenase inhibitor
0,067  0,060  Antibiotic
0,201  0,195  Antiprotozoal (Plasmodium)
0,019  0,013  Antibiotic Anthracycline-like
0,073  0,068  MAP kinase kinase 7 inhibitor
0,044  0,040  Glucose-6-phosphate isomerase inhibitor
0,073  0,069  Phosphodiesterase IV inhibitor
0,082  0,078  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,108  0,104  Interleukin 4 antagonist
0,107  0,104  DNA repair enzyme inhibitor
0,053  0,051  Pregnane X receptor antagonist
0,051  0,049  Fatty acid synthase inhibitor
0,061  0,060  Endocannabinoid uptake inhibitor
0,113  0,112  Psychosexual dysfunction treatment
0,133  0,133  Pyruvate kinase inhibitor

